Больной, закончивший исследование,

Больной, закончивший исследование, исключается из анализа эффективности в следующих случаях:
• Отсутствие важных данных обследования, являющихся критериями оценки эффективности;
• Значительное нарушение плана испытаний.

Все больные, досрочно прекратившие участие в исследовании, которым хотя бы однократно вводился препарат, учитываются при оценке безопасности.

Результаты (английский) 1:

The patient who study is excluded from the analysis of the effectiveness in the following cases:• The absence of survey data that are important criteria for the assessment of the effectiveness;• A significant violation of the test plan.All patients in the study stopped ahead of schedule, which at least once entered a drug considered when evaluating security.

Результаты (английский) 2:

The patient who completed the study, is excluded from the efficacy analysis in the following cases:
• Absence of important survey data, which are criteria of effectiveness;
• Significant violation test plan. All patients prematurely discontinued the study, which at least once injected drug, taken into account in the safety assessment .

Результаты (английский) 3:

the patient, resident study was excluded from the analysis of the performance in the following cases:
- lack of important survey data, which are criteria of effectiveness evaluation;.- a significant violation of the test plan.

all patients with early have interrupted their participation in the study, which was introduced at least once drug are taken into account in assessing the security. "